OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
February 01, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming February Investor Conferences
January 31, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award
January 18, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Jan. 18, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
January 03, 2022 08:00 ET
|
OptimizeRx Corporation
Panel to take place January 6, 2022 at 8:30am ET ROCHESTER, Mich., Jan. 03, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360
December 29, 2021 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Dec. 29, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”)(Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
December 22, 2021 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Dec. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer – an Indication with Limited Patient Population
December 15, 2021 14:38 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Dec. 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Recognized by Digital Health Awards® Fall 2021 for TelaRep™ and its COVID-19 Text Message Campaign
December 08, 2021 08:00 ET
|
OptimizeRx Corporation
- COVID-19 Consumer Health Communications Campaign won silver in the “Mobile Digital Health Resources: Text Messaging” category- TelaRep Interactive EHR Communication received a merit award in the...
OptimizeRx Ranked Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
November 23, 2021 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Nov. 23, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate at the Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 22, 2021 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Nov. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...